BE888396A - Capsules diagnostiques et therapeutiques et leur preparation, - Google Patents

Capsules diagnostiques et therapeutiques et leur preparation,

Info

Publication number
BE888396A
BE888396A BE0/204467A BE204467A BE888396A BE 888396 A BE888396 A BE 888396A BE 0/204467 A BE0/204467 A BE 0/204467A BE 204467 A BE204467 A BE 204467A BE 888396 A BE888396 A BE 888396A
Authority
BE
Belgium
Prior art keywords
diagnostic
preparation
capsules
therapeutic
therapeutic capsules
Prior art date
Application number
BE0/204467A
Other languages
English (en)
Inventor
N Morcos
T Haney
P Wedeking
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of BE888396A publication Critical patent/BE888396A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1262—Capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/204467A 1980-04-14 1981-04-13 Capsules diagnostiques et therapeutiques et leur preparation, BE888396A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/140,341 US4349529A (en) 1980-04-14 1980-04-14 Diagnostic and therapeutic capsules and method of producing

Publications (1)

Publication Number Publication Date
BE888396A true BE888396A (fr) 1981-10-13

Family

ID=22490796

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/204467A BE888396A (fr) 1980-04-14 1981-04-13 Capsules diagnostiques et therapeutiques et leur preparation,

Country Status (11)

Country Link
US (1) US4349529A (fr)
JP (1) JPS56161052A (fr)
AU (1) AU553720B2 (fr)
BE (1) BE888396A (fr)
CA (1) CA1181687A (fr)
CH (1) CH661872A5 (fr)
DE (1) DE3115053C2 (fr)
FR (1) FR2480124A1 (fr)
GB (1) GB2073589B (fr)
IT (1) IT1137544B (fr)
ZA (1) ZA812305B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5456663A (en) * 1984-05-25 1995-10-10 Lemelson; Jerome H. Drugs and methods for treating diseases
US4702228A (en) * 1985-01-24 1987-10-27 Theragenics Corporation X-ray-emitting interstitial implants
WO1989012305A1 (fr) * 1988-06-07 1989-12-14 Nutech, Inc. Procede de decontamination en particulier de materiaux plastiques selectionnes et classiques qui ont ete contamines par radioactivite, et articles
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
US5227165A (en) * 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5221535A (en) * 1989-11-13 1993-06-22 Nova Pharmaceutical Corporation Sustained release formulations of insect repellent
IE904098A1 (en) * 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US5314678A (en) * 1992-01-28 1994-05-24 Mallinckrodt Medical, Inc. Sodium iodide 131 I capsules
US6537518B1 (en) 1994-01-21 2003-03-25 Sirtex Medical Limited Particulate material
DE69533744T2 (de) * 1994-01-21 2005-11-10 Sirtex Medical Ltd., Burswood Yttria partikelförmiges gut
US5993374A (en) * 1997-06-17 1999-11-30 Radiance Medical Systems, Inc. Microcapsules for site-specific delivery
CA2494358A1 (fr) * 2002-07-31 2004-02-05 Pharmacia Corporation Forme posologique pharmaceutique conservant un profil de dissolution stable au stockage
US20040081689A1 (en) * 2002-10-24 2004-04-29 Dunfield John Stephen Pharmaceutical dosage form and method of making
US8733274B2 (en) * 2006-10-20 2014-05-27 Hewlett-Packard Development Company, L.P. Tube mounted inkjet printhead die
US7867548B2 (en) * 2006-10-27 2011-01-11 Hewlett-Packard Development Company, L.P. Thermal ejection of solution having solute onto device medium
US20100284912A1 (en) * 2007-12-04 2010-11-11 Bracco Diagnostics Inc. Homogenization of a radiopharmaceutical using sonification and/or rotor-stator technology to produce a homogenous suspension, emulsion, mixture or solid suspension of immiscible ingredients
US10299745B2 (en) 2014-12-29 2019-05-28 Loyola University Of Chicago Traceable devices for gastrointestinal use and methods of use and manufacturing the same
CN113750260B (zh) * 2021-07-29 2023-03-31 原子高科股份有限公司 一种治疗用放射性碘[i-131]化钠胶囊及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1683466A (en) * 1927-05-09 1928-09-04 Joseph A Horigan Capsule
US2911338A (en) * 1954-03-09 1959-11-03 Abbott Lab Capsules and method of producing
NL269886A (fr) * 1960-10-04
BE609341A (fr) * 1960-10-26
DE2140177A1 (de) * 1971-08-11 1973-02-22 Hoechst Ag Oral applizierbare, radioaktives jod enthaltende kapsel zur schilddruesenfunktionsdiagnostik und verfahren zu ihrer herstellung
US3780170A (en) * 1972-07-03 1973-12-18 Warner Lambert Co Tasteless methenamine mandelate
JPS5653351Y2 (fr) * 1976-09-06 1981-12-11
JPS5345344U (fr) * 1976-09-22 1978-04-18
JPS5398949U (fr) * 1977-01-14 1978-08-10
JPS52128952A (en) * 1977-04-02 1977-10-28 Yoshino Kogyosho Co Ltd Method of molding decorated synthetic resin container body or cap
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles

Also Published As

Publication number Publication date
GB2073589A (en) 1981-10-21
CA1181687A (fr) 1985-01-29
IT1137544B (it) 1986-09-10
IT8121084A0 (it) 1981-04-10
JPS56161052A (en) 1981-12-11
DE3115053A1 (de) 1982-02-18
JPH0379326B2 (fr) 1991-12-18
IT8121084A1 (it) 1982-10-10
US4349529A (en) 1982-09-14
FR2480124B1 (fr) 1983-07-18
ZA812305B (en) 1982-04-28
CH661872A5 (fr) 1987-08-31
GB2073589B (en) 1985-01-16
DE3115053C2 (de) 1994-07-28
FR2480124A1 (fr) 1981-10-16
AU6908781A (en) 1981-10-22
AU553720B2 (en) 1986-07-24

Similar Documents

Publication Publication Date Title
BE888396A (fr) Capsules diagnostiques et therapeutiques et leur preparation,
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
DE3175083D1 (en) Pharmaceutical compounds, their preparation and use
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
FR2504931B1 (fr) Ionomeres modifies, leur preparation et leur utilisation
AT366911B (de) Medikamentenkapsel
BE872886A (fr) Steroides, leur preparation et leur utilisation therapeutique
OA07412A (fr) Benzoazacycloalhyl-spiro-imidazolidines leur préparation et leur application en thérapeutique.
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE863702A (fr) Tetrazolylcarbamoylquinoleines et leur preparation
BE887323A (fr) 17alpha-acyloxy-5 beta-corticoides et 17alpha-acyloxy-5alpha-corticoides, leur preparation et leur utilisation
BE884076A (fr) Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
BE894056A (fr) 2-oxo-azetidines, leur preparation et leur utilisation
FR2516509B1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
BE877328A (fr) Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique
MA19965A1 (fr) 3',5'-diarabinosides, leur preparation et leur application en therapeutique
ES502737A0 (es) Mejoras en la fabricacion de capsulas de medicamento
BE888608A (fr) Esters de steroide-oxazoles, leur preparation et leur utilisation,
LU81350A1 (fr) Arylalkyl-et aryloxyalkyl-phosphonates,leur preparation et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
RO76074A2 (fr) Medicament energisaant
BE891204A (fr) Derives de naphtyridine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRACCO INTERNATIONAL B.V.

Effective date: 20000430